Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment

BACKGROUND: Patients with renal impairment receiving classical anticoagulation for venous thromboembolism (VTE) are at increased risk of bleeding and possibly pulmonary embolism. We examined the efficacy and safety of oral rivaroxaban in patients with VTE with and without renal impairment. METHODS:...

Full description

Saved in:
Bibliographic Details
Published in:Thromb J
Main Authors: Bauersachs, Rupert M, Lensing, Anthonie WA, Prins, Martin H, Kubitza, Dagmar, Pap, Ákos F, Decousus, Hervé, Beyer-Westendorf, Jan, Prandoni, Paolo
Format: Artigo
Language:Inglês
Published: BioMed Central 2014
Subjects:
Original Basic Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351845/
https://ncbi.nlm.nih.gov/pubmed/25750589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-9560-12-25
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items